Literature DB >> 11117957

The epidemiology of adenovirus infections in Greater Manchester, UK 1982-96.

R J Cooper1, R Hallett, A B Tullo, P E Klapper.   

Abstract

Data relating to 3313 adenovirus isolates from patients in Greater Manchester, UK between 1982 and 1996 were analysed using chi2 tests and 95% confidence intervals. Of the 3098 isolates that were typed, 18.6% were serotype 2, 14.9% serotype 3, 12.1% serotype 1 and 10.9% serotype 41. There was evidence of a seasonal occurrence of serotype 7 (March-August), serotype 2 (January-April), serotype 4 (June-August) and subgenus F (September-November). Children less than 5 years old were the most common group of patients with adenovirus infection (61.3%) compared to 24.2% for adults and only 5.6% for school children (5-15 years). Gastric symptoms were the most common amongst infants (47.6%) followed by respiratory (27.5%) and general symptoms (12.9%). In adults, the overwhelming clinical condition was conjunctivitis (88.9%). Despite the traditional association with adenoviruses, remarkably few cases of pharyngoconjunctival fever were recorded (1.7%).

Entities:  

Mesh:

Year:  2000        PMID: 11117957      PMCID: PMC2869606          DOI: 10.1017/s0950268899004550

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  32 in total

1.  PCR analysis of egyptian respiratory adenovirus isolates, including identification of species, serotypes, and coinfections.

Authors:  David Metzgar; Miguel Osuna; Samuel Yingst; Magda Rakha; Kenneth Earhart; Diaa Elyan; Hala Esmat; Magdi D Saad; Adriana Kajon; Jianguo Wu; Gregory C Gray; Margaret A K Ryan; Kevin L Russell
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

2.  First evidence of genotypes Ad3a16 and Ad3a18 in North America, obtained by genetic analysis of infectious human adenovirus from wastewaters of two urban communities in Canada.

Authors:  Sinisa Vidovic; Mahmoud Aly; Cecily Flemming; Susan Springthorpe; Syed A Sattar
Journal:  Appl Environ Microbiol       Date:  2011-04-22       Impact factor: 4.792

3.  Implications of the innate immune response to adenovirus and adenoviral vectors.

Authors:  Seth M Gregory; Shoab A Nazir; Jordan P Metcalf
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

4.  Molecular identification of adenovirus causing respiratory tract infection in pediatric patients at the University of Malaya Medical Center.

Authors:  Juraina Abd-Jamil; Boon-Teong Teoh; Eddy H Hassan; Nuruliza Roslan; Sazaly Abubakar
Journal:  BMC Pediatr       Date:  2010-07-02       Impact factor: 2.125

5.  Detection of antibodies against adenovirus protein IX, fiber, and hexon in human sera by immunoblot assay.

Authors:  Ulrike Bauer; Gisela Flunker; Kornelia Bruss; Knut Kallwellis; Herbert Liebermann; Tanja Luettich; Manfred Motz; Werner Seidel
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

6.  Effects of bacterial and viral co-infections of mycoplasma pneumoniae pneumonia in children: analysis report from Beijing Children's Hospital between 2010 and 2014.

Authors:  Qing Song; Bao-Ping Xu; Kun-Ling Shen
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 7.  Treatment of adenovirus infections in the immunocompromised host.

Authors:  P Ljungman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-10       Impact factor: 3.267

8.  Receptor usage of a newly emergent adenovirus type 14.

Authors:  Hongjie Wang; Sebastian Tuve; Dean D Erdman; André Lieber
Journal:  Virology       Date:  2009-05-10       Impact factor: 3.616

9.  Human adenovirus 14a: a new epidemic threat.

Authors:  Gregory C Gray; Margaret L Chorazy
Journal:  J Infect Dis       Date:  2009-05-15       Impact factor: 5.226

10.  Reassessment of high prevalence human adenovirus detections among residents of two refugee centers in Kenya under surveillance for acute respiratory infections.

Authors:  Xinwei Wu; Xiaoyan Lu; Eileen Schneider; Jamal A Ahmed; M Kariuki Njenga; Robert F Breiman; Rachel B Eidex; Dean D Erdman
Journal:  J Med Virol       Date:  2018-11-08       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.